NSW pharmacists given special authority to supply essential medicines
NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires.
The NSW Chief Health...
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
The impact of air pollution
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...
Supporting patients to quit vaping: an important role for pharmacists
With vaping rates rising and regulatory changes reshaping access, pharmacists play an increasingly important role.
Consultant pharmacist excellence awarded
Two pharmacists were honoured at PSA’s Consultant Pharmacist Conference (CPC26), held from 29–31 May 2026 on the Gold Coast.













